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Background: The average sequence divergence between
each enterovirus 71 (EV-71) subgenotype has been previ-
ously established using VP1 gene sequences. However, VP1
only encompasses 12% of the complete genome and other
non-structural genomic regions are also phylogenetically
informative. In the present study, using the complete EV-71
genome sequences, pairwise sequence comparisons (PASC)
were analyzed to standardize the genotyping of EV-71.
Methods: With the recent availability of 41 complete EV-
71 genomes of various subgenotypes and 12 complete human
enterovirus A(HEV-A) genomes, genome sequence similari-
ties were visualized by plotting the frequency distribution
of the pairwise identity percentages.
Results: Using the complete genome, the average
sequence divergences between HEV-A and EV-71 were
26.15% (22—28%) at the nucleotide level and 15.01% (9—21%)
at the amino acid level. The average nucleotide sequence
divergence between EV-71 genotypes (A, B and C) was
19.64% (17—21%), while between and within the subgeno-
types (B2-B5 and C1-C4) were 10.75% (6—14%) and 3.09%
(1—5%) respectively. Based on these results, subgenotype
C4 which has nucleotide sequence divergence of 18.13%
(17—20%) when compared with other subgenotypes C (C1-
C3) exceeded the cutoff divergence value assigned for EV-71
subgenotyping, and should be redesignated as a new geno-
type D. On the other hand, subgenotype B5 which has only
average nucleotide sequence divergence of 5.56% (4—7%)
when compared with other subgenotypes B4 did not justify
its designation as a new subgenotype.
Conclusion: The average divergence values generated
through PASC between members of the EV-71 and HEV-A can
systematically delineate the HEV-A serotypes, EV-71 geno-
types and subgenotypes.
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Background: Human Papillomavirus is universally
accepted as a necessary cause for invasive cervical carci-
noma. The incidence of cervical cancer is 510,000 cases
worldwide of which 132,000 cases occur in India with high
mortality rate. The causal role of human papilloma virus in
all cancers of the uterine cervix has been established. HPV
infection is overwhelming the most important predictor
of increased risk for cervical cancer and its premalignant
lesions. There is limited data available for HPV prevalence
in younger population.
Aim: To analyze the prevalence of HPV infection in young
women (16—24 years). Methodology: 1000 samples of exfo-
liated cervical cells collected (in DIGENE STM) from women
aged 16—24 years, resident of an urban slum area in Delhi
were tested. The samples were processed for Hybrid Cap-
ture (HC2) using DIGENE HC2 assay. HPV DNA was detected
by PCR using PGMY consensus primers. HPV genotyping was
done for HPV positive samples using the Reverse Line blot
array.
Results: 84/1000 (8.4%) samples were positive for HPV.
30/84 (35.7%) samples were HPV 16 positive and 5/84 (6%)
sample was positive for HPV 18. Mixed HPV infections were
found in 34 samples.
Conclusions: The prevalence of HPV in the above popu-
lation was found to be 8.4%. HPV 16 was the most common
type detected. This study for HPV prevalence and type can
give an indication of the natural history of HPV infection
in the younger age group in whom the HPV infection rate
is known to be the highest. Prevalence in younger popula-
tion in our region will give an estimation of patterns of HPV
infection and enable to identify the target population for
vaccination.
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Background: The burden of adenovirus as a respira-
tory disease etiology in sub-Saharan Africa has not been
well studied. In the developed world it is a signiﬁcant
cause of childhood respiratory disease throughout the year.
Our laboratory coexisting with Kenya’s National Inﬂuenza
Center (NIC) - developed the ﬁrst sustained, comprehen-
sive sentinel surveillance system for viral upper respiratory
infections in Kenya. This effort began in July 2006 as a sub-
activity of the Kenyan National Inﬂuenza Network. In total,
fourteen different respiratory viruses are under surveillance
including adenovirus.
Method: Eight public hospitals distributed across and
representing the entire country comprise our collection
site network. Nasopharyngeal swab specimens are col-
lected within 72 hours of symptom onset from consenting
patients presenting with inﬂuenza like illness. Specimens
are transported in liquid nitrogen to the NIC where they are
inoculated in the Hep2 cell line and incubated. Immunoﬂu-
orescence assays are carried out using group speciﬁc
antibodies for adenoviruses on all cultures showing cyto-
pathic effect
Results: Out of 360 viruses isolated from patient sam-
ples in the initial one-and-half years of the surveillance, 120
isolates (33.3%) were adenovirus. 60% of these cases were
male, and all were children under ﬁve years. 71% originated
in western Kenya. Adenovirus infection occurred throughout
the year.
